FIRM FIXED PRICENO SET ASIDE USED.

10X GENOMICS, INC. - GEM-X UNIVERSAL 3' GENE EXPRESSION V4, 16 SAMPLES

PIID: 75N98C26F00001
Signed Date: Feb 18, 2026Effective Date: Apr 13, 2022End Date: Closed on Feb 19, 2026
Award $
$23K
Vendor
10X GENOMICS, INC.
NAICS
325413
Signed Date
Feb 18, 2026

Key Details

Dollars Obligated
$22,585.5
Base & All Options
$22,585.5
Awarding Sub-Agency
National Institutes of Health
Product Service Code
6640 - LABORATORY EQUIPMENT AND SUPPLIES
Extent Competed
COMPETED UNDER SAP
Number of Offers
1
Place of Performance
PLEASANTON, CA, 945883260, CD-CA-14

Description

GEM-X UNIVERSAL 3' GENE EXPRESSION V4, 16 SAMPLES

Context & Analysis

On Feb 18, 2026, Department of Health and Human Services obligated $22,585.5 to 10X GENOMICS, INC. for gem-x universal 3' gene expression v4, 16 samples. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PLEASANTON, CA.

Contractor Information

Contractor: 10X GENOMICS, INC.
UEI: D1NLDEZ14TV5
CAGE Code: 7EWK7
Location: PLEASANTON, CA

Stay Updated

Get notified about new opportunities matching your interests.

Related